Home Article BioScrip reports loss in revenues

BioScrip reports loss in revenues

BioScrip reports loss in revenues

Also Noted

Default Author Head Shot

By HME News Staff

Updated Fri May 6, 2016

DENVER - BioScrip reported net revenues of $238.5 million for the first quarter of 2016, compared to $244.4 million for the same period a year ago, a decrease of 2.4%. Adjusted EBITDA was $7.4 millionvs. $4.9 million. The company said it was “pleased” with results and that the decrease in revenue stems from a planned shift in revenue mix away from lower margin chronic infusion revenue to its core infusion business

Comments

To comment on this post, please log in to your account or set up an account now.